Rocket Lab shares edge higher despite CFO's planned stock sale
Stocktwits reports Rocket Lab stock rose overnight as CFO Adam Spice filed to sell $7.7 million in shares, while Citizens kept its $90 target.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Rocket Lab (RKLB) gained 1% in overnight trading late Monday, even though CFO Adam Spice proposed selling shares worth roughly $7.7 million. Citizens kept its Market Outperform rating and $90 price target, which implies about 72% upside from current levels, despite the postponed debut of Neutron.
According to Stocktwits, the filing covers 140,157 shares obtained through an option exercise the same day. The sale falls under a Rule 10b5-1 plan adopted June 3, 2026. Over the previous three months Spice completed five sales totaling more than $23 million. Director Nina Armagno also filed to sell 10,926 shares, worth about $598,000, which lifts the combined planned sales to $8.27 million. Her shares come from restricted stock units received October 30, under a plan adopted September 19, 2025.
On Monday the stock slipped 5% to $52.07, its second consecutive losing session.
why it matters
The stock is down about 25% this year, so the planned insider sales and the delay to Neutron's first launch weigh on sentiment. Pre-scheduled sales under 10b5-1 plans carry no fresh company information, but traders will watch whether Electron demand can offset the slower timeline for the next rocket.
tags
instruments
sources
- RKLB Stock Rises Overnight Despite CFO’s $7.7M Sale Plan — This Analyst Sticks To $90 Target Even Amid Neutron Setback — Stocktwits, 3 November 2026 at 02:18 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗